Daiichi Sankyo made its fourth attempt in the Delhi High Court on Monday to secure the assets of Malvinder Singh and Shivinder Singh (and their affiliate companies), after claiming that the former Ranbaxy promoters had made false statements in earlier affidavits tendered before the court. The affidavits in question had been submitted by the Singh brothers in line with directions issued on a petition seeking the enforcement of a Rs 2,562 crore Singapore arbitral award in favour of the Japanese pharma major.
Senior advocate C A Sundaram, appearing on behalf of Daiichi began the Monday's proceedings by highlighting a Rs 1,500